Description

Establishing reliable patient-derived gastric cancer models can be challenging when researchers need to maintain the biological characteristics of primary tumor samples while achieving consistent expansion in vitro. Traditional two-dimensional cancer cell culture systems may not fully represent the complex architecture and cellular diversity observed in gastric tumors, limiting their application in advanced cancer research and drug response studies.

Biofargo Human Gastric Cancer Organoid Culture Kit (BiofargohGasCO-100) is a serum-free gastric cancer organoid culture medium system designed for the establishment, expansion, and maintenance of human gastric cancer organoids derived from tumor tissue samples. The optimized formulation provides a supportive 3D culture environment to help researchers generate stable gastric tumor organoid models for downstream research applications.

This human gastric cancer organoid culture kit is designed for laboratories studying patient-derived gastric cancer organoids, tumor biology, and personalized oncology research. By supporting long-term organoid maintenance and expansion, Biofargo gastric cancer organoid medium provides a practical solution for developing advanced 3D cancer models used in drug screening, disease mechanism studies, and tumor microenvironment research.

BiofargohGasCO-100 contains human gastric cancer organoid basal medium A and culture additive B. After mixing, the complete medium provides a ready-to-use culture system without requiring additional optimization of individual components.

Specifications

Product Name	Biofargo Human Gastric Cancer Organoid Culture Kit
SKU	BiofargohGasCO-100
Product Type	Human gastric cancer organoid culture medium system
Application	Patient-derived gastric cancer organoid establishment, expansion, and 3D tumor model research
Culture System	Serum-free defined organoid culture system
Basal Medium A	96 mL
Culture Additive B	4 mL
Total Complete Medium Volume	100 mL after mixing
Storage of Basal Medium	4°C for 3 months; -20°C for 12 months
Storage of Additive	-20°C for 6 months
Recommended Use	Research use only
Regulatory Status	For research use only. Not for clinical diagnosis or therapeutic use.

Features

Serum-Free Gastric Cancer Organoid Culture System — Designed for human gastric cancer organoid establishment and expansion without serum supplementation.
Patient-Derived Tumor Organoid Research Support — Provides a specialized culture environment for generating gastric cancer 3D models from tumor tissue samples.
Ready-to-Use Medium Format — Combination of basal medium A and additive B simplifies workflow preparation and reduces medium optimization requirements.
Supports Long-Term Organoid Maintenance — Enables stable gastric cancer organoid expansion for multiple passages according to research requirements.
Suitable for 3D Cancer Model Development — Supports applications requiring physiologically relevant tumor organoid platforms.
Consistent Research Performance — Defined formulation helps improve experimental reproducibility across gastric cancer organoid culture workflows.
Flexible Downstream Research Applications — Compatible with gastric cancer biology studies, drug screening research, and tumor model development.

Human Gastric Cancer Organoid Culture Workflow

Generating reliable patient-derived gastric cancer organoids requires a controlled workflow that preserves tumor-derived cells while providing suitable conditions for 3D growth and expansion. Biofargo Human Gastric Cancer Organoid Culture Kit is designed to support the complete workflow from primary gastric tumor tissue processing to gastric cancer organoid establishment and maintenance.

Step 1: Primary Gastric Tumor Tissue Preparation

Fresh human gastric cancer tissue samples are prepared under sterile conditions and processed into small tissue fragments. Proper tissue preparation helps improve subsequent cell recovery and supports successful patient-derived gastric cancer organoid establishment.

Wash tumor tissue samples with sterile PBS to remove unwanted components.
Cut tissue samples into approximately 1–3 mm³ fragments for downstream processing.

Step 2: Tissue Dissociation and Cell Collection

Processed tissue fragments are dissociated into cell populations suitable for organoid culture. After filtration and centrifugation, collected cells are prepared for embedding within extracellular matrix materials.

Tissue digestion performed at 37°C for approximately 15–45 minutes depending on tissue characteristics.
Cell suspension is filtered to remove undigested tissue fragments.
Optional red blood cell removal can be performed when required.

Step 3: Gastric Cancer Organoid Formation

Prepared gastric cancer cells are mixed with extracellular matrix and seeded into culture plates. Following matrix solidification, complete gastric cancer organoid culture medium is added to support three-dimensional tumor organoid formation.

Recommended cell density: 1 × 10⁵ – 1 × 10⁶ cells/mL.
Matrix gel incubation: 37°C for approximately 15–25 minutes.
Culture conditions: 37°C, 5% CO₂.

Step 4: Organoid Expansion and Maintenance

Established human gastric cancer organoids can be maintained and expanded for downstream cancer research applications, including tumor biology studies, drug screening models, and precision oncology research workflows.

Research Performance Characteristics

Biofargo Human Gastric Cancer Organoid Culture Kit is developed to provide a practical culture solution for researchers establishing gastric cancer organoid models from primary tumor samples. The optimized serum-free formulation supports organoid growth and maintenance while helping researchers reduce workflow complexity.

Culture Format	Three-dimensional gastric cancer organoid culture
Sample Source	Human gastric cancer tissue samples
Culture Goal	Establishment, expansion, and maintenance of gastric cancer organoid models
Culture Advantage	Ready-to-use serum-free organoid medium system
Expansion Capability	Supports stable expansion for multiple passages according to experimental requirements
Research Model Type	Patient-derived gastric cancer 3D tumor model

Applications

Biofargo Human Gastric Cancer Organoid Culture Kit provides a specialized platform for researchers developing patient-derived gastric cancer organoid models. These 3D tumor models can better represent tumor heterogeneity compared with conventional two-dimensional cancer cell culture systems and are increasingly used in advanced oncology research.

Gastric Cancer Drug Screening

Patient-derived gastric cancer organoids provide an advanced in vitro platform for evaluating compound responses and studying therapeutic sensitivity. Biofargo gastric cancer organoid culture medium supports researchers performing cancer drug screening studies using human tumor-derived models.

High-value screening models for anti-cancer compound evaluation.
Comparison of treatment responses among different gastric cancer organoid models.
Research platform for investigating drug resistance mechanisms.

Patient-Derived Tumor Organoid Research

Human gastric cancer organoids preserve important characteristics derived from original tumor samples, making them useful tools for studying tumor biology and patient-specific cancer models.

Patient-derived gastric cancer model establishment.
Tumor heterogeneity investigation.
Gastric cancer progression and biological mechanism studies.

Precision Oncology Research

Gastric cancer organoid models are increasingly applied in precision oncology research because they provide a personalized experimental system for evaluating tumor responses under controlled laboratory conditions.

Personalized treatment research models.
Tumor response evaluation studies.
Patient-specific cancer research workflows.

3D Cancer Model Development

Compared with traditional cancer cell culture, three-dimensional gastric cancer organoids provide a more representative tumor model for investigating interactions between cancer cells and their surrounding environment.

3D gastric tumor model construction.
Tumor microenvironment research.
Advanced cancer biology studies.

Why Choose Biofargo Human Gastric Cancer Organoid Culture Kit?

Developing reliable gastric cancer organoid models requires more than supporting cell growth. Researchers need a culture system that simplifies primary tissue processing workflows while maintaining a suitable environment for long-term tumor organoid research.

Biofargo Human Gastric Cancer Organoid Culture Kit provides a dedicated gastric cancer organoid culture medium designed around the needs of researchers working with human tumor-derived samples. The serum-free formulation, ready-to-use format, and compatibility with 3D tumor model workflows help laboratories establish consistent gastric cancer organoid platforms for oncology research.

For researchers studying gastric cancer mechanisms, drug responses, or patient-derived tumor models, BiofargohGasCO-100 offers a focused solution for building reliable human gastric cancer organoid culture systems.

FAQ

What is Biofargo Human Gastric Cancer Organoid Culture Kit used for?

Biofargo Human Gastric Cancer Organoid Culture Kit is a serum-free gastric cancer organoid culture medium system designed for the establishment, expansion, and maintenance of human gastric cancer organoids derived from tumor tissue samples. It is intended for research applications including gastric cancer biology studies, 3D tumor model development, and drug screening research.

What is a human gastric cancer organoid culture system?

A human gastric cancer organoid culture system is an in vitro 3D culture platform used to generate tumor-like structures from human gastric cancer tissue samples. Compared with conventional two-dimensional cancer cell culture, gastric cancer organoids provide a more representative model for studying tumor characteristics and biological responses.

Can gastric cancer organoids be used for drug screening research?

Yes. Patient-derived gastric cancer organoids are widely used as advanced cancer research models for compound evaluation, treatment response studies, and investigation of potential drug resistance mechanisms. Biofargo gastric cancer organoid culture medium supports workflows requiring stable 3D tumor models for drug screening applications.

What are the advantages of patient-derived gastric cancer organoids?

Patient-derived gastric cancer organoids can retain important characteristics from original tumor samples and provide a personalized cancer research model. They are useful for studying tumor heterogeneity, gastric cancer mechanisms, and precision oncology research applications.

Is Biofargo Human Gastric Cancer Organoid Culture Kit serum-free?

Yes. Biofargo Human Gastric Cancer Organoid Culture Kit is a serum-free organoid culture medium system designed to support human gastric cancer organoid establishment and expansion while providing a defined research workflow.

What samples can be used with this gastric cancer organoid medium?

Biofargo Human Gastric Cancer Organoid Culture Kit is designed for research workflows using human gastric cancer tissue samples to establish patient-derived gastric tumor organoid models.

How is the complete gastric cancer organoid medium prepared?

The complete medium is prepared by mixing 96 mL of human gastric cancer organoid basal medium A with 4 mL of culture additive B. After mixing, the resulting 100 mL complete medium can be used for gastric cancer organoid culture workflows.

How long can gastric cancer organoids be maintained using Biofargo culture medium?

Biofargo Human Gastric Cancer Organoid Culture Kit supports stable gastric cancer organoid expansion and maintenance for multiple passages according to research requirements. The product documentation reports maintenance for at least 3 passages, with some organoids achieving more than 10 passages under suitable conditions.

Can this product be used for precision oncology research?

Yes. Patient-derived gastric cancer organoid models supported by Biofargo culture medium can be used as research tools for precision oncology studies, including tumor response evaluation and personalized cancer model development.

Is Biofargo Human Gastric Cancer Organoid Culture Kit intended for clinical use?

No. Biofargo Human Gastric Cancer Organoid Culture Kit is intended for research use only and is not approved for clinical diagnosis, treatment, or therapeutic applications.

Human Gastric Cancer Organoid Medium Kit